Becton Dickinson and Co vs SpaceX — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while SpaceX trades at $134.72 (market cap $1.76T). The key difference: SpaceX is far larger — about 35.6× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays a 2.32% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| BDX | SPCX | |
|---|---|---|
Market Cap | $49.41B | $1.76T |
Sector | Health | Technology |
52-Week High | $185.39 | $202.09 |
52-Week Low | $138.62 | $108.27 |
Enterprise Value | $65.51B | $1.70T |
Dividend Yield | 2.32% | — |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →